Gerald W. McLaughlin
CIK 1495412 · Chief Executive Officer · last filed 2026-05-07
Gerald W. McLaughlin is a Chief Executive Officer who has filed 21 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for ALLR, was dated May 7, 2026. Across all open-market trades the lifetime net is +$51.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.82M
4
21
$51.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLR | Director | 70,000 | $1.43 | $100.1K | $0 | 3 | 2026-05-07 |
| AYTU | Director | 31,401 | $2.15 | $67.5K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Chief Executive Officer | 0 | $1.15 | $0 | $51.2K | 9 | 2021-03-19 |
| PATH | VP, ChiefCommercial Officer | 156,651 | $10.55 | $1.65M | $0 | 3 | 2013-01-22 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | ALLR | Grant (A) | +45,000 | $0 | EDGAR |
| 2025-01-24 | ALLR | Grant (A) | — | $0 | EDGAR |
| 2025-01-24 | ALLR | Grant (A) | — | $0 | EDGAR |
| 2021-04-12 | AYTU | Grant (A) | +6,500 | $0 | EDGAR |
| 2021-03-19 | Neos Therapeutics, Inc. (NEOS) Delisted | Disp (D) | −270,171 | $0 | EDGAR |
| 2021-03-16 | Neos Therapeutics, Inc. (NEOS) Delisted | Tax (F) | −44,329 | -$37.4K | EDGAR |
| 2020-03-16 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | +290,000 | $0 | EDGAR |
| 2019-03-22 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-04 | Neos Therapeutics, Inc. (NEOS) Delisted | Grant (A) | — | $0 | EDGAR |